Skip to main content

Antibiotic Overuse a Slippery Slope for STI Prevention, says AHF

AIDS Healthcare Foundation (AHF) welcomes the decision by the European Union to reduce antimicrobial resistance (AMR) by 20% in the bloc by 2030. As part of the push, the strategy should discourage widespread use of pre- and post-exposure prophylaxis as the primary method of prevention for sexually transmitted infections (STI) in favor of promoting consistent condom use.

“Wealthy countries are courting another public health disaster by abandoning condoms and shifting STI prevention to bio-medical interventions. An overreliance on antibiotics is incubating treatment resistant strains of gonorrhea, chlamydia, and syphilis at an alarming rate. If conventional drugs begin to fail on a population level, these once common, treatable bacteria might turn into deadly diseases,” said AHF President Michael Weinstein. “Condoms must be a part of the solution to addressing AMR because repeated bacterial exposure inevitably leads to drug resistance, and only barrier protection can help ensure antibiotics remain a viable treatment tool in the long run.”

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

Contacts

US MEDIA CONTACT:

Ged Kenslea, Senior Director, Communications, AHF

+1 323 308 1833 work, +1.323.791.5526 mobile

gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF

+1 323.308.1829

denys.nazarov@aidshealth.org

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.